Lung protective therapy using long-term neuromuscular blockade guided by the airway occlusion pressure in severe ARDS due to COVID-19 pneumonia: A case report-Reference-Cited by-同舟云学术

Lung protective therapy using long-term neuromuscular blockade guided by the airway occlusion pressure in severe ARDS due to COVID-19 pneumonia: A case report

Published:2022-05-01 Issue:3 Volume:29 Page:211-215
ISSN:1340-7988
Container-title:Journal of the Japanese Society of Intensive Care Medicine
language:en
Short-container-title:Nihon Shuchu Chiryo Igakukai zasshi

Author:

Kikuyama Kazuki¹,Maruo Hiroko¹,Ichikawa Yuki¹,Watanabe Taro¹,Ohsugi Koichi¹,Shono Atsuko¹,Kimura Tomoyuki²,Kotani Toru¹

Affiliation:

1. Department of Intensive Care Medicine, Showa University Hospital

2. Division of Respiratory Medicine and Allergology, Showa University Hospital

Publisher

Japanese Society of Intensive Care Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jsicm/29/3/29_29_211/_pdf

Reference13 articles.

1. 1) Grasselli G, Zangrillo A, Zanella A, et al; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323:1574-81. Erratum in: JAMA 2021;325:2120.

2. 2) Yoshida T, Fujino Y, Amato MB, et al. Fifty Years of Research in ARDS. Spontaneous Breathing during Mechanical Ventilation. Risks, Mechanisms, and Management. Am J Respir Crit Care Med 2017;195:985-92.

3. 3) Tonelli R, Busani S, Tabbì L, et al. Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study. Am J Respir Crit Care Med 2021;204:725-8.

4. 4) Spangler J, Martley TJ, Schieber T, et al. Assessment of narcotic, sedative, and neuromuscular blocker needs of patients with COVID-19 requiring invasive mechanical ventilation. Am J Health Syst Pharm 2021;78:1168-70.

5. 5) Courcelle R, Gaudry S, Serck N, et al; on behalf the COVADIS study group. Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study. Crit Care 2020;24:446.